Notice2025-20329
Medicare Program; Announcement of the Re-Approval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 19, 2025
Effective
November 19, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Medicare & Medicaid Services
Abstract
This document corrects technical errors that appeared in the notice published in the May 24, 2024, Federal Register titled "Medicare Program; Announcement of the Reapproval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1998".
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 221 (Wednesday, November 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 221 (Wednesday, November 19, 2025)]
[Notices]
[Pages 52074-52075]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-20329]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3450-CN]
Medicare Program; Announcement of the Re-Approval of the Joint
Commission as an Accreditation Organization Under the Clinical
Laboratory Improvement Amendments of 1988; Correction
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (HHS).
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: This document corrects technical errors that appeared in the
notice published in the May 24, 2024, Federal Register titled
``Medicare Program; Announcement of the Reapproval of the Joint
Commission as an Accreditation Organization Under the Clinical
Laboratory Improvement Amendments of 1998''.
DATES:
Effective date: This correction notice is effective November 19,
2025.
Applicability date: The corrections in this notice are applicable
to the re-approval of the Joint Commission as an Accreditation
Organization Under the Clinical Laboratory Improvement Amendments
(CLIA) of 1988 from May 24, 2024 through May 24, 2030.
FOR FURTHER INFORMATION CONTACT: Raymond Castillo, (312) 886-3595.
SUPPLEMENTARY INFORMATION:
I. Background
In FR Doc. 2024-11421 of May 24, 2024 (89 FR 45900 through 45901),
there were technical errors that are identified and corrected in this
correcting document.
II. Summary of Errors
On page 45900, in the SUMMARY section, we inadvertently omitted
several entries from the list of specialties and subspecialties under
the Clinical Laboratory Improvement Amendments (CLIA) of 1988. We also
made inadvertent technical errors in several bulleted paragraphs.
III. Correction of Errors
In FR Doc. 2024-11421 of May 24, 2024 (89 FR 45900 through 45901),
make the following correction:
1. On page 45900,
a. First column, sixth full paragraph (SUMMARY section), lines 15
through 22, the phrase ``Toxicology, and Endocrinology; Hematology,
including routine hematology and coagulation; Immunohematology,
including ABO Group, D (Rho) typing, Unexpected Antibody Detection,
Compatibility Testing, and Antibody Identification; Pathology,
including Histopathology, Oral Pathology, and Cytology.'' is corrected
to read, ``Toxicology, Endocrinology, and Urinalysis; Hematology,
including routine hematology and coagulation; Immunohematology,
including ABO Group, D (Rho) typing, Unexpected Antibody Detection,
Compatibility Testing, and Antibody Identification; Pathology,
including Histopathology, Oral Pathology, Cytology, Histocompatibility,
Radiobioassay, and Clinical Cytogenetics.''
b. Second column,
(1) Third bulleted paragraph, lines 2 and 3, the phrase
``Toxicology, and Endocrinology.'' is corrected to read, ``Toxicology,
Endocrinology, and Urinalysis.''.
(2) Sixth bulleted paragraph, lines 1 through 3, the paragraph
``<bullet> Pathology, including Histopathology, and Oral Pathology, and
Cytology.'' is corrected to read as follows:
``<bullet> Histocompatibility.
<bullet> Radiobioassay.
<bullet> Clinical Cytogenetics.''
<bullet> Pathology, including Histopathology, and Oral Pathology,
and Cytology.''
c. Third column,
(1) Third bulleted paragraph, lines 2 and 3, the phrase
``Toxicology, and Endocrinology.'' is corrected to read, ``Toxicology,
Endocrinology, and Urinalysis.''.
(2) Sixth bulleted paragraph, lines 1 through 3, the paragraph
``<bullet> Pathology, including Histopathology, and Oral Pathology, and
Cytology.'' is corrected to read as follows:
``<bullet> Pathology, including Histopathology, and Oral Pathology,
and Cytology.
<bullet> Histocompatibility.
<bullet> Radiobioassay.
<bullet> Clinical Cytogenetics.''
The Director of the Office of Strategic Operations and Regulatory
Affairs of the Centers for Medicare & Medicaid Services (CMS), Kathleen
Cantwell,
[[Page 52075]]
having reviewed and approved this document, authorizes Trenesha Fultz-
Mimms, who is the Federal Register Liaison, to electronically sign this
document for purposes of publication in the Federal Register.
Trenesha Fultz-Mimms,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2025-20329 Filed 11-18-25; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on November 19, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.